iBankCoin
Home / Finance (page 48)

Finance

Do Exchange-Traded Funds Pose A Threat to Stability?

Remarkably, Exchange-Traded Funds have grown from $0 to $1 trillion in just 20 years. As they are still a relatively new and rapidly growing asset class, it is time to consider how they might contribute to the instability of financial markets.

Read the article here.

Comments »

ZeroHedge: Margin Stanley ($MS) Faces Apocalyptic Margin Call (lol)

Last week it was Bank of America. This time it is the bank once again known as Margin Stanley. From the 10-Q: “In connection with certain OTC trading agreements and certain other agreements associated with the Institutional Securities business segment, the Company may be required to provide additional collateral or immediately settle any outstanding liability balances with certain counterparties in the event of a credit rating downgrade. At March 31, 2012, the following are the amounts of additional collateral, termination payments or other contractual amounts (whether in a net asset or liability position) that could be called by counterparties under the terms of such agreements in the event of a downgrade of the Company’s long-term credit rating under various scenarios: $868 million (A3 Moody’s/A- S&P); $5,177 million (Baa1 Moody’s/ BBB+ S&P); and $7,206 million (Baa2 Moody’s/BBB S&P). Also, the Company is required to pledge additional collateral to certain exchanges and clearing organizations in the event of a credit rating downgrade. At March 31, 2012, the increased collateral requirement at certain exchanges and clearing organizations under various scenarios was $160 million (A3 Moody’s/A- S&P); $1,600 million (Baa1 Moody’s/ BBB+ S&P); and $2,400 million (Baa2 Moody’s/BBB S&P).” As a reminder, on February 15 Moody’s warned it’s considering downgrades of US banks and may cut Morgan Stanley as much as, you guessed it, 3 notches. Needless to say this explains why “CEO James Gorman has met with the ratings firm more often than usual in the past quarter.” Net – if the firm sees a 3 notch downgrade as warned the hit will be an AIG-shudder inducing $9.6 billion, or one third of the company’s market cap, and enough to leave all shareholders wishing they had exposure to Greece, and no exposure to Morgan Stanley.

Full Article

Comments »

SAC TAKES 5% STAKES IN $WNR and $YELP

It looks like Stevie might be reading some outlandish websites.

Western Refining: SAC Capital discloses 5.4% stake in 13G filing

Yelp: SAC Capital discloses 5.1% stake in 13G filing

Source sec.gov

Comments »

John Kerry Invests Like a Congressman

In mid-October 2008, as the Treasury was discussing which banks would be bailed out in the Trouble Asset Relief Program (TARP), Kerry bought up to $550,000 worth of Citigroup stock and up to $350,000 worth of Bank of America shares. Days later, the American public learned that Citigroup would receive $50 billion from the TARP fund and up to $277 billion in additional loan guarantees. Bank of America also received $50 billion from TARP.

During the contentious healthcare debate in 2009, Schweizer noted, Kerry loaded up on pharmaceutical stocks, purchasing close to $750,000 worth of shares in one company—Teva Pharmaceuticals—in the month of November alone.

Drug companies were viewed to be among the major beneficiaries of the Democratic healthcare legislation. Pharmaceuticals “kicked in $80 billion to help make the bill work, but stand to make 10 times that amount in revenues from added government and government-subsidized business,” liberal columnist Howard Fineman wrote inNewsweek.

Teva stock was trading at about $50 a share when Kerry started buying, but jumped to $62 a share after the healthcare bill was passed, an increase of nearly 25 percent. After Obama signed the bill into law, Kerry sold his Teva shares, realizing tens of thousands in capital gains.

Kerry also bought shares of ResMed, a company that makes medical devices, which surged more than 70 percent after the healthcare bill’s passage. Throughout the healthcare negotiations, Kerry consistently opposed efforts to increase taxes on companies like ResMed.

He also purchased stock in Thermo Fisher Scientific, a firm providing products and services to hospitals, at $35 a share. After passage, they were trading at $50 a share, an increase of more than 40 percent.

Comments »

An Alternative View of the Student Loan Industry

I found this to be a very interesting read on our student loan problem.

Other accounts of the student loan debt problem put the estimates of total debt to $5-$7 trillion due to derivatives traded behind the market place.

Full look

 

 

Comments »